Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults With Moderate to Severe Atopic Dermatitis Treated With Dupilumab
Conditions
Interventions
Dupilumab
Placebo
Locations
42
United States
Birmingham, Alabama, United States
Fort Smith, Arkansas, United States
Long Beach, California, United States
Los Angeles, California, United States
Mission Viejo, California, United States
Rolling Hills Estates, California, United States
Start Date
August 5, 2014
Primary Completion Date
September 15, 2015
Completion Date
September 15, 2015
Last Updated
May 7, 2020
NCT06116526
NCT06461897
NCT07262983
NCT06389136
NCT06342713
NCT07223697
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions